AXCELLA HEALTH - Trademark Details
Status: 819 - SU - Registration Review Complete
Serial Number
87062063
Word Mark
AXCELLA HEALTH
Status
819 - SU - Registration Review Complete
Status Date
2022-02-10
Filing Date
2016-06-06
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-06-02
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
MAKHDOOM, SAIMA
Statements
Disclaimer with Predetermined Text
"HEALTH"
Goods and Services
proteins, biochemicals in the nature of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in scientific and medical research; nutrients and nutritive products, namely, proteins in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of beverages, food products and food supplements for human and non-human use; proteins for the food industry in the nature of proteins, polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals for in vitro and in vivo scientific research
Goods and Services
Dietary supplements for human and animal use; dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, and joints; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints; dietary and nutritional supplements
Goods and Services
Research and development of products in the nature of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; characterization of metrics and biomarkers, namely, development and evaluation of biochemical, biological, or analytical assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-06-14
Primary Code
005
First Use Anywhere Date
2021-11-05
First Use In Commerce Date
2021-11-05
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Christina M. Licursi, Esq.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Child | 87983740 |
Trademark Events
Event Date | Event Description |
2016-06-09 | NEW APPLICATION ENTERED IN TRAM |
2016-06-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-09-16 | ASSIGNED TO EXAMINER |
2016-09-16 | NON-FINAL ACTION WRITTEN |
2016-09-16 | NON-FINAL ACTION E-MAILED |
2016-09-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2017-02-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2017-03-16 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2017-03-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-03-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-04-05 | FINAL REFUSAL WRITTEN |
2017-04-05 | FINAL REFUSAL E-MAILED |
2017-04-05 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2017-09-20 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2017-09-20 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2017-10-05 | EXPARTE APPEAL RECEIVED AT TTAB |
2017-10-05 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
2017-10-05 | EX PARTE APPEAL-INSTITUTED |
2017-10-05 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2017-10-18 | ASSIGNED TO LIE |
2017-10-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-10-23 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-10-23 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2017-10-26 | NON-FINAL ACTION WRITTEN |
2017-10-26 | NON-FINAL ACTION E-MAILED |
2017-10-26 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-04-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-04-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-04-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-05-07 | SUSPENSION LETTER WRITTEN |
2018-05-07 | LETTER OF SUSPENSION E-MAILED |
2018-05-07 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
2018-11-07 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2019-05-11 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2019-05-11 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2019-11-11 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2020-04-28 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
2020-04-30 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-04-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-04-30 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-05-13 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-06-02 | PUBLISHED FOR OPPOSITION |
2020-06-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-07-28 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-01-28 | TEAS EXTENSION RECEIVED |
2021-01-28 | TEAS REQUEST TO DIVIDE RECEIVED |
2021-02-16 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-01-28 | DIVISIONAL REQUEST RECEIVED |
2021-02-22 | DIVISIONAL PROCESSING COMPLETE |
2021-01-28 | EXTENSION 1 FILED |
2021-02-22 | EXTENSION 1 GRANTED |
2021-02-23 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-02-23 | CORRECTED NOA E-MAILED |
2021-07-27 | TEAS EXTENSION RECEIVED |
2021-07-27 | EXTENSION 2 FILED |
2021-07-27 | EXTENSION 2 GRANTED |
2021-07-29 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2022-01-28 | TEAS STATEMENT OF USE RECEIVED |
2022-01-28 | USE AMENDMENT FILED |
2022-02-03 | STATEMENT OF USE PROCESSING COMPLETE |
2022-02-10 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2022-02-11 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |